US EditionCarlsmed’s Nasdaq Debut Gets $100.5M
Summary by San Diego Business Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Carlsmed’s Nasdaq Debut Gets $100.5M
CARLSBAD – Commercial-stage medical device and technology company Carlsmed, Inc. has gone public, launching its initial public offering on the Nasdaq Global Select Market under the symbol CARL. Carlsmed made 6.7 million shares of common stock available at $15 per share as part of the IPO, estimated to net the company $100.5 million. The company […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
